[{"author":"PresciencePoint","content":"New Risk Factor from $K confirms our prediction that the reversal of DSOs and DPO build will wreak havoc on perform\u2026 https:\/\/t.co\/9WhzOYrxuj","pubdate":"20190306143605","NumFavorite":4,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Is a Kashi impairment forthcoming? Changes in fair value suggest it could be, and soon. $K https:\/\/t.co\/JX0L5FoYsu","pubdate":"20190306150347","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Think Kraft Heinz's atrocious results and dividend cut were bad? $KHC pales in comparison to $K in valuation, accou\u2026 https:\/\/t.co\/FsDdomL1bt","pubdate":"20190306170228","NumFavorite":7,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Investors fled $KHC after it was too late. Will $K shareholders make the same mistake? Both companies face the same\u2026 https:\/\/t.co\/4diodofMEy","pubdate":"20190307133115","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$K\u2019s day of reckoning will come soon enough as its capital structure is beyond tight @KelloggCompany https:\/\/t.co\/WvvQbmtZwZ","pubdate":"20190307165629","NumFavorite":5,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$K remains more levered than it appears, even with our very conservative estimates - full report here -\u2026 https:\/\/t.co\/IErgVc1vLb","pubdate":"20190308144316","NumFavorite":4,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@ActivistInsight yesterday highlighted our $K update to their email subscribers. We maintain a high conviction in o\u2026 https:\/\/t.co\/Ld7yZvRnmD","pubdate":"20190313160853","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Kellogg destroyed billions of market value since it acquired Keebler 20 years ago; $4.0B\u2192$1.3B! Price on the low si\u2026 https:\/\/t.co\/OtQzpXm3EJ","pubdate":"20190401161103","NumFavorite":19,"NumShare":11,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We filed this today regarding $MDXG -https:\/\/t.co\/7d4Bi8zrLg","pubdate":"20190402213525","NumFavorite":5,"NumShare":5,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@SamAntar Respect to redemption","pubdate":"20190406042958","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @IvanaBoastsky: @PresciencePoint \n\n#SEC finally charged Celadon et al.\n\nCongrats and have a nice rest of spring.","pubdate":"20190425152132","NumFavorite":0,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In 2017 we published several reports exposing and quantifying FRAUD at Celadon $CGIP. Today, the SEC and DOJ have o\u2026 https:\/\/t.co\/5s2cNJJFk8","pubdate":"20190425160048","NumFavorite":17,"NumShare":9,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @TheJusticeDept: Celadon Group, Inc. Enters into Corporate Resolution for Securities Fraud and Agrees to Pay $42.2 Million in Restitutio\u2026","pubdate":"20190425171008","NumFavorite":0,"NumShare":114,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @BarbarianCap: this was a @PresciencePoint report https:\/\/t.co\/gqijHppoWx","pubdate":"20190426122311","NumFavorite":0,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @herbgreenberg: Wait, the $K CFO just started, and now he\u2019s out? Hmmmm\u2026..","pubdate":"20190502131225","NumFavorite":0,"NumShare":6,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Earnings plummet 37% @KelloggCompany today. CFO out after only two years; CFO will be the third since 2017. CAO als\u2026 https:\/\/t.co\/bKrd7lV0f8","pubdate":"20190502140041","NumFavorite":6,"NumShare":8,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We believe our slate possesses the necessary healthcare &amp; biopharma experience, turnaround &amp; restatement experience\u2026 https:\/\/t.co\/grVaoPMfWb","pubdate":"20190507160415","NumFavorite":6,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Today we nominated 4 highly-qualified candidates to the board of MiMedx Group $MDXG that we believe will help the c\u2026 https:\/\/t.co\/0Nxpa8As5V","pubdate":"20190507160415","NumFavorite":43,"NumShare":71,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$MDXG's potential has been jeopardized by ineffective Board oversight and alleged wrongdoing by former mgmt, which\u2026 https:\/\/t.co\/AN8bYCugzT","pubdate":"20190507175952","NumFavorite":6,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We believe a refreshed Board, with highly-qualified members that are free of any attachment to past actions or lega\u2026 https:\/\/t.co\/bowUX2T0pf","pubdate":"20190507175952","NumFavorite":5,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"As outlined in our Jan report, we believe $MDXG is substantially undervalued, &amp; with the proper leadership in place\u2026 https:\/\/t.co\/cNfpGqqxNd","pubdate":"20190507175953","NumFavorite":7,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Great reporting by @MelinAnders - this is exactly why $MDXG needs a refreshed board which can provide better oversi\u2026 https:\/\/t.co\/eck8u7hszI","pubdate":"20190509142215","NumFavorite":7,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @IvanaBoastsky: @PresciencePoint\n\nDo a little chest thumping if you want.\n\nFWIW, one of the SEC guys on this matter, JP, is a real mensc\u2026","pubdate":"20190509215034","NumFavorite":0,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"The president of a Celadon Corp. subsidiary pleaded guilty to criminal charges connected with the massive #fraud we\u2026 https:\/\/t.co\/4wZtuFFWsL","pubdate":"20190510143349","NumFavorite":10,"NumShare":5,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In April 2017 we published a detailed report on Celadon exposing and quantifying the massive accounting #fraud a th\u2026 https:\/\/t.co\/hqtJAP1vqW","pubdate":"20190510143721","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We filed our preliminary proxy statement last night for $MDXG. You can read it here: https:\/\/t.co\/WHXx04VVdz We bel\u2026 https:\/\/t.co\/0k4grdEADJ","pubdate":"20190510150532","NumFavorite":3,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"https:\/\/t.co\/XpEbN6ypbL","pubdate":"20190510191924","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We look forward to working with the newly refreshed board to realize substantial value for all $MDXG shareholders. https:\/\/t.co\/GvLMRcA0rb","pubdate":"20190530123500","NumFavorite":17,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We are very excited to have reached an agreement for a broad reconstitution of the board of $MDXG. Under the plan,\u2026 https:\/\/t.co\/lEuFGPDPRP","pubdate":"20190530123500","NumFavorite":28,"NumShare":7,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: We issued a letter explaining what is at stake at our upcoming Annual Meeting. Help our company move forward by voting the BLUE\u2026","pubdate":"20190603145240","NumFavorite":0,"NumShare":7,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"MiMedx Shareholders Should Visit https:\/\/t.co\/KQuJJCGF0p for information on how to vote in the upcoming annual meet\u2026 https:\/\/t.co\/3WpbLU1k1D","pubdate":"20190604140558","NumFavorite":2,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: Visit https:\/\/t.co\/D4jRcgXP6J to read about our three new director nominees up for election at the 2018 Annual Meeting. Every v\u2026","pubdate":"20190604140615","NumFavorite":0,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: MiMedx just posted a presentation for investors. Download the presentation here: https:\/\/t.co\/9iVS5fN4bX. Vote the BLUE card to\u2026","pubdate":"20190605233835","NumFavorite":0,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: MDXG encourages all shareholders to vote the BLUE card today! Voting instructions are available at https:\/\/t.co\/9iVS5fN4bX. $MD\u2026","pubdate":"20190605233839","NumFavorite":0,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: The MiMedx Board is committed to taking action to ensure the Company is positioned for future success. See our investor present\u2026","pubdate":"20190606174147","NumFavorite":0,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: Every vote counts! Help MiMedx move forward by voting the BLUE card today! Voting instructions are available at https:\/\/t.co\/9i\u2026","pubdate":"20190607142133","NumFavorite":0,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"MiMedx Urges Shareholders to Vote \"FOR\" All of the Board's Qualified Nominees on the BLUE Proxy Card https:\/\/t.co\/JzPAaF67FP @$MDXG","pubdate":"20190607142232","NumFavorite":2,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"MiMedx Issues Additional Information to Shareholders https:\/\/t.co\/eAQ8ZogQJx $MDXG","pubdate":"20190610133902","NumFavorite":1,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: The MiMedx Board believes the election of Pete Petit or either of his nominees would be damaging to the Company\u2019s turnaround ef\u2026","pubdate":"20190610194240","NumFavorite":0,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: Who is Pete Petit? Read a simple summary of the findings from the Audit Committee\u2019s independent investigation to learn the fact\u2026","pubdate":"20190610194244","NumFavorite":0,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Leading Independent Proxy Advisory Firms ISS and Egan-Jones Recommend That MiMedx Shareholders Vo...\u2026 https:\/\/t.co\/3AGiUoj4v9","pubdate":"20190611133503","NumFavorite":2,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"ISS Report on $MDXG: \"Choosing between the company's nominees and those of the dissident, it appears clear that the\u2026 https:\/\/t.co\/QnWDi8xaGM","pubdate":"20190611134416","NumFavorite":2,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: Independent experts Institutional Shareholder Services and Egan Jones are recommending that MiMedx shareholders vote FOR all th\u2026","pubdate":"20190611193040","NumFavorite":0,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: Read what expert neutral proxy advisors, Institutional Shareholder Services and Egan-Jones, said about Pete Petit &amp; his nominee\u2026","pubdate":"20190611193045","NumFavorite":0,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: Glass Lewis, a leading independent proxy advisory firm, considers Pete Petit unfit for board service at MiMedx. Read what Glass\u2026","pubdate":"20190612151816","NumFavorite":0,"NumShare":5,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Typically, lenders will demand a significant equity kicker when lending to companies in financial distress. Thus, B\u2026 https:\/\/t.co\/hR2aYH645g","pubdate":"20190612164041","NumFavorite":6,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Yesterday, $MDXG announced that it has raised $75m of NON-DILUTIVE debt financing from Blue Torch Capital.  We beli\u2026 https:\/\/t.co\/azWJxApUJt","pubdate":"20190612164041","NumFavorite":10,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Furthermore, we believe this additional capital gives $MDXG the necessary dry powder to reinvest in its business, e\u2026 https:\/\/t.co\/2OCTfODnbp","pubdate":"20190612164042","NumFavorite":5,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"MiMedx Highlights Skills and Experience of Director Nominees https:\/\/t.co\/w3rg4xfvOa via @YahooFinance $MDXG","pubdate":"20190613133251","NumFavorite":0,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"On Jan 7th, we published our bullish Initiation Report on $MDXG.  Since then, a number of positive developments hav\u2026 https:\/\/t.co\/ub2Ta1086m","pubdate":"20190614130845","NumFavorite":5,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"On May 23rd, $MDXG revealed the results of its 15-month Audit Committee investigation. Based on the investigation f\u2026 https:\/\/t.co\/El1lcDVjfl","pubdate":"20190614130845","NumFavorite":5,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$MDXG also made significant progress in executing its turnaround plan. This progress includes 1) reaching an agreem\u2026 https:\/\/t.co\/4ldUGjMSLG","pubdate":"20190614130846","NumFavorite":6,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Per the latest proxy, $MDXG employed 320 sales reps as of Apr 2019. Assuming $0.9m sales per rep, which is inline w\u2026 https:\/\/t.co\/kURv6Or9wT","pubdate":"20190614132952","NumFavorite":5,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@Mimedx\u2019s recently filed proxy and credit agreement contain several positive updates regarding the current health of the Co\u2019s business $MDXG","pubdate":"20190614132952","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Per the credit agreement, $MDXG had $99m in cash on 6\/10\/19. Using this #, we est that the Co has generated ~$61m o\u2026 https:\/\/t.co\/P9ik3t0VKE","pubdate":"20190614132953","NumFavorite":7,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @MiMedx: MiMedx\u2019s 2018 Annual Meeting will be on Monday, June 17! MiMedx recommends all shareholders vote the BLUE card FOR the Company\u2019\u2026","pubdate":"20190614172650","NumFavorite":0,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"MiMedx Shareholders Overwhelmingly Support Election of All Three of MiMedx's Highly Qualified Director Nominees\u2026 https:\/\/t.co\/KA7p9mfZX2","pubdate":"20190617140602","NumFavorite":7,"NumShare":6,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We want to thank our fellow $MDXG shareholders for their overwhelming support in nominating our highly-qualified Bo\u2026 https:\/\/t.co\/FJMQjz5GLO","pubdate":"20190617154015","NumFavorite":5,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Concerns raised by the @WSJ over $MDXG's Amniofix injectable products should be contextualized. Amniofix represents\u2026 https:\/\/t.co\/U1skdRcpVi","pubdate":"20190617154016","NumFavorite":5,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Despite a &gt;2x increase in price since our Initiation Report, we believe $MDXG is still significantly undervalued.\u2026 https:\/\/t.co\/pjNYVsFysp","pubdate":"20190617154016","NumFavorite":4,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"These restructuring charges should NOT be excluded from non-GAAP results as they have persisted for nearly a decade\u2026 https:\/\/t.co\/FQlAwfEtsT","pubdate":"20190618152554","NumFavorite":7,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Today, $K announced yet another restructuring program (the 2nd this year).  Based on the $50m Europe reorg + the $3\u2026 https:\/\/t.co\/sMV4bqaKpV","pubdate":"20190618152554","NumFavorite":9,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Another positive development from the new @MiMedx board \u201cMiMedx Announces Agreement Regarding 2019 and 2020 Shareho\u2026 https:\/\/t.co\/SvBneLIVm1","pubdate":"20190808222815","NumFavorite":7,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @opinion_joe: Here\u2019s my take on the $MDXG brouhaha. Spoiler alert: \u2066@AlderLaneeggs\u2069 and his allies are trying to destroy a company whose\u2026","pubdate":"20190819113316","NumFavorite":0,"NumShare":22,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Prescience Point remains $MDXG's largest shareholder and, as of Nov 11th, owns ~[7.7]% of @MiMedx\u2019s outstanding sha\u2026 https:\/\/t.co\/ZdxDblAM4u","pubdate":"20191111143717","NumFavorite":13,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Much of our continued bullishness is driven by increased optimism over the potential for $MDXG's micronized amnioti\u2026 https:\/\/t.co\/v3kQIwOR0m","pubdate":"20191111143717","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"As a recent example, in Nov 2019, @AmerAcadPainMed published a study showing that micronized amniotic injections si\u2026 https:\/\/t.co\/Dn1seBpHoi","pubdate":"20191111162501","NumFavorite":8,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We believe that $MDXG will eventually receive approval for both indications given the substantial and mounting evid\u2026 https:\/\/t.co\/GXAL8iueF6","pubdate":"20191111162501","NumFavorite":4,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@AmerAcadPainMed The injectable market for joints exceeds $12B annually &amp; Amniofix is far ahead of competing produc\u2026 https:\/\/t.co\/Y19RIbFSfQ","pubdate":"20191111200413","NumFavorite":9,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"CFO move at $MDXG is yet another positive and necessary step in @MiMedx\u2019s transformation as it gears up to exit a s\u2026 https:\/\/t.co\/i2voZeB5PH","pubdate":"20191122141443","NumFavorite":10,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Today\u2019s developments mark another hugely positive step in $MDXG's recovery and confirm the key points of our Long thesis.","pubdate":"20191126205236","NumFavorite":14,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In our report, we concluded that $MDXG's wrongdoing was mostly limited to end-of-Q channel stuffing &amp; that the vast\u2026 https:\/\/t.co\/aes7cSkOIN","pubdate":"20191126205237","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"This was confirmed by today\u2019s SEC complaint which revealed that \u201cat least 6% to 14%\u201d of $MDXG's reported revenue ea\u2026 https:\/\/t.co\/tf7Nc3ATO8","pubdate":"20191126205238","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In our Initiation Report, we also concluded that any penalty from the SEC would not be sizable enough to cause\u2026 https:\/\/t.co\/mz1oUiNOYO","pubdate":"20191126205239","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"This was confirmed by today\u2019s announcement that $MDXG had settled with the SEC for just $1.5m \u2013 the exact same amou\u2026 https:\/\/t.co\/9vc3HKSiSC","pubdate":"20191126205240","NumFavorite":8,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Finally, we applaud the SEC for their indictment of former $MDXG CEO Parker \u201cPete\u201d Petit and two other former execu\u2026 https:\/\/t.co\/UKPZQINHnI","pubdate":"20191126205240","NumFavorite":9,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @BarbarianCap: $CGI was @PresciencePoint report https:\/\/t.co\/hbapJQRVc3","pubdate":"20191205212210","NumFavorite":0,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @IvanaBoastsky: @PresciencePoint\n\nhttps:\/\/t.co\/HoR511cdYG","pubdate":"20191205214938","NumFavorite":0,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Our original report from April 2017 can be found here https:\/\/t.co\/6wwKzlKu8z","pubdate":"20191206143726","NumFavorite":4,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In addition to the company paying a $42M fine, we commend the DOJ and the SEC for charging former Celadon executive\u2026 https:\/\/t.co\/qCQjBKJUyR","pubdate":"20191206143726","NumFavorite":17,"NumShare":8,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @PresciencePoint: In addition to the company paying a $42M fine, we commend the DOJ and the SEC for charging former Celadon executives w\u2026","pubdate":"20191207180436","NumFavorite":0,"NumShare":8,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @FreightWaves: We will be doing live coverage of the Celadon Bankruptcy today across our social media channels.  Be sure to tune in for\u2026","pubdate":"20191209145500","NumFavorite":0,"NumShare":5,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Today's bankruptcy of Celadon Group is unfortunate, but it is something we predicted upon identifying and exposing\u2026 https:\/\/t.co\/nKWW568kPs","pubdate":"20191209151710","NumFavorite":9,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @_davidelman: Celadon indeed has filed for Chapter 11; short seller @PresciencePoint two years ago said Celadon's shares failed \"to refl\u2026","pubdate":"20191209151735","NumFavorite":0,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Our newest long idea $BRMK offers immediate upside as a temporary market inefficiency dissipates. We conservatively\u2026 https:\/\/t.co\/MxJWhItATQ","pubdate":"20191210135503","NumFavorite":17,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Valuation discount to peers is unwarranted and should close rapidly. $BRMK https:\/\/t.co\/th4VKnY9lB","pubdate":"20191210135628","NumFavorite":4,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Stringent loan requirements will continue to provide margin of safety and limit downside risk. $BRMK https:\/\/t.co\/uMy8ZOD7UE","pubdate":"20191210140007","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"All returns are unlevered as $BRMK uses zero debt, a rarity amongst its peers. https:\/\/t.co\/Dxug3mPhGB","pubdate":"20191210140008","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Over $200m cash ready to be deployed to pipeline of opportunities in new markets with favorable demographic trends\u2026 https:\/\/t.co\/25q9Lt1wl8","pubdate":"20191210140009","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Accretive management fees from privately raised capital will provide optionality for additional earnings\/dividends\u2026 https:\/\/t.co\/ojBT8FlVwc","pubdate":"20191210140010","NumFavorite":4,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"RT @rrpre: \"You have a very incestuous organization that is unlike any other public company that I've ever seen\"\n\n@SaacksAttack and I got i\u2026","pubdate":"20191211183639","NumFavorite":0,"NumShare":13,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We are short $MDLA and believe fair value is &gt;50% below current levels. Shares are trading over 13x sales despite a\u2026 https:\/\/t.co\/VTMt9m0c4v","pubdate":"20200116160006","NumFavorite":38,"NumShare":8,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"The TAM $MDLA has pitched investors is wildly unrealistic and overstated by at least 2x. We estimate the actual mar\u2026 https:\/\/t.co\/8QgFGAeIQd","pubdate":"20200116163032","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Third-party research firm Marketsandmarkets drastically lowered growth expectations in 2019 for the customer experi\u2026 https:\/\/t.co\/r1Dbu1UosB","pubdate":"20200116165700","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$MDLA only provided two years of historical financials in its IPO documents despite a 20-year operating history whi\u2026 https:\/\/t.co\/cvBybBlyW6","pubdate":"20200116171640","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Excluding M&amp;A, FY 21 guidance implies revenue growth will slow to below 20.0% for the first time in over a decade!\u2026 https:\/\/t.co\/WPs2dxd0wJ","pubdate":"20200116173732","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Current valuation is ~5x what $MDLA valued itself internally less than a year ago.  Recent expiry of IPO share lock\u2026 https:\/\/t.co\/5Ty1YdKVYY","pubdate":"20200116175824","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"It appears $MDLA window dressed profitability to create the illusion that margin was turning positive. https:\/\/t.co\/cu6fmvlly5","pubdate":"20200116182018","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"One accounting gimmick $MDLA used was higher cost capitalization. https:\/\/t.co\/LDvzCBnjiO","pubdate":"20200116184456","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Normalized cost capitalization levels show $MDLA would have been unprofitable in every quarter it disclosed. https:\/\/t.co\/hlLLjZVo0w","pubdate":"20200116191142","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Insiders unloaded massive stakes at significantly lower prices.  Founders sold 1.6M shares in Oct. 2018 at ~6.50\/sh\u2026 https:\/\/t.co\/vrWbjfsYBH","pubdate":"20200116193453","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Since 2012, Medallia has done four equity raises, each at a lower valuation than the current multiple (P\/LTM sales)\u2026 https:\/\/t.co\/TnLx9asb2l","pubdate":"20200116195919","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Most of the sell-side is using the WRONG share count of ~128m vs the correct share count of ~177m\u2026meaning the curre\u2026 https:\/\/t.co\/T2hVkh36W3","pubdate":"20200116203109","NumFavorite":7,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"The Street isn\u2019t properly accounting for over 50m of deep in-the-money $MDLA options. The actual diluted share coun\u2026 https:\/\/t.co\/MjloTuZxbA","pubdate":"20200116205916","NumFavorite":4,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Baird\u2019s bullish research note yesterday used the WRONG share count and understated $MDLA market cap by over 25.0%!\u2026 https:\/\/t.co\/uSfN60pTkC","pubdate":"20200117163358","NumFavorite":4,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Important note: this Form 4 was filed late after hours on 01\/21\/20 (i.e. after 5pm PST).  Is the timing of the fili\u2026 https:\/\/t.co\/p5oQMOIWBx","pubdate":"20200122155957","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$MDLA CEO sold over 300,000 shares (&gt;10% of his beneficial ownership) since the IPO lock-up expiry last week.  As w\u2026 https:\/\/t.co\/8Safne9mor","pubdate":"20200122155957","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Friday night filing reveals @Medallia's CEO unloaded another &gt;10% tranche of his stock. Since our report and the IP\u2026 https:\/\/t.co\/KNmEvaJGpH","pubdate":"20200127160424","NumFavorite":4,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@Medallia As $MDLA insiders cash out, new investors are paying a huge price for weaker growth. @Medallia's internal\u2026 https:\/\/t.co\/Hne7tWheEp","pubdate":"20200128140317","NumFavorite":4,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Throughout FY 19 $MDLA stock was consistently valued around ~$6.50\/share by Board of Directors with input from mana\u2026 https:\/\/t.co\/lmfbLAg4rC","pubdate":"20200128150949","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Three months into FY 20, $MDLA determined the addition of a new CEO &amp; CFO + commencement of IPO readiness procedure\u2026 https:\/\/t.co\/2WWzUi26oQ","pubdate":"20200128153125","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Despite doubling its valuation a few months earlier, $MDLA upped it by 30% to $17\/share at midpoint when it initial\u2026 https:\/\/t.co\/IazGlE1iAN","pubdate":"20200128155041","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"At ~$30, share price implies $MDLA is 5x more valuable than a year ago. However, $MDLA guided for FY21 rev growth t\u2026 https:\/\/t.co\/K4b0Zm1LYp","pubdate":"20200128161439","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We believe many public investors had no idea $MDLA raised its internal valuation by ~3x in the six months leading u\u2026 https:\/\/t.co\/H5CVU9lE4w","pubdate":"20200128163233","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"The winners of this IPO are the VCs &amp; insiders NOT public shareholders. The tight float pre-lock up, limited histor\u2026 https:\/\/t.co\/odagzIAN3A","pubdate":"20200128165501","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"If you think Casper\u2019s $CSPR valuation is nuts, check out @Medallia $MDLA. Via @nypostbiz on Casper: \u201cThe notion thi\u2026 https:\/\/t.co\/iXKQ5ciCfZ","pubdate":"20200129141629","NumFavorite":4,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$MDLA's competition is heating up. On its Q4 19 Earnings Call, $SAP (Qualtrics) called out higher win rates vs.\u2026 https:\/\/t.co\/IenSxkcmiD","pubdate":"20200129153245","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Recall, on its Q3 19 Earnings Call, $SAP highlighted it had an \u201cacceleration of win rates\u201d vs. $MDLA. https:\/\/t.co\/lDACbDcK9n","pubdate":"20200129153246","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@Medallia @nypostbiz $CSPR cuts IPO price range by 36%, well below its private market valuation a year ago. $MDLA w\u2026 https:\/\/t.co\/aiFnzCfgP7","pubdate":"20200205165357","NumFavorite":2,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Yet another late Friday night filing shows $MDLA CTO sold his second &gt;10% stake in the last three months.  $MDLA\u2019s\u2026 https:\/\/t.co\/d8Oo7N9WsL","pubdate":"20200224143050","NumFavorite":7,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"As the Start-Up Boom Deflates, Tech Is Humbled https:\/\/t.co\/jYkN3u0tkA via @eringriffith and @NYTimes $MDLA #TechWRECKoning","pubdate":"20200225162256","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$MDLA went public at the very peak of this chart! #TechWRECKoning CC: @eringriffith https:\/\/t.co\/GxKdbpLnJN","pubdate":"20200225164726","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"This week, $CMCM announced that Google had removed its apps from the Play Store due to compliance violations which\u2026 https:\/\/t.co\/Y0VgidiGIC","pubdate":"20200225203323","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In our October 2017 report, we predicted that Google would ban Cheetah Mobile apps from the Play Store due to what\u2026 https:\/\/t.co\/VKkI7xjQyV","pubdate":"20200225203323","NumFavorite":1,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We issued a new report on @Medallia this morning. $MDLA has used M&amp;A to mask rapidly deteriorating organic revenue\u2026 https:\/\/t.co\/FEuijFvjdN","pubdate":"20200317142928","NumFavorite":8,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Despite acquiring LivingLens in Feb. 2020, $MDLA reiterated its FY 21 guidance implying organic growth will be belo\u2026 https:\/\/t.co\/VRlXCxM5vq","pubdate":"20200317142929","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Over last year, $MDLA spent $110M on M&amp;A but provided little\/no guidance on rev contribution.  M&amp;A only picked pick\u2026 https:\/\/t.co\/MFhH5EJyBX","pubdate":"20200317143109","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"COVID-19 implications could be meaningful, lasting, and very negative. $MDLA's core customers are some of the most\u2026 https:\/\/t.co\/KllUtpaQPB","pubdate":"20200317143407","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Path to profitability still a fairy tale. $MDLA has been unprofitable for 20 years despite minimal competition in c\u2026 https:\/\/t.co\/b8ng2uUhlN","pubdate":"20200317143407","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We want to congratulate @Mimedx and CEO Tim Wright for completing the arduous process of restating its financials.\u2026 https:\/\/t.co\/nNCwdA2WSd","pubdate":"20200318132928","NumFavorite":6,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In our Jan 2019 report, we concluded that the vast majority of $MDXG's revenue was real &amp; sustainable, &amp; that only\u2026 https:\/\/t.co\/PJYCRVKWJg","pubdate":"20200318133312","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"This was confirmed by $MDXG's Super 10K \u2013 The Co\u2019s reported net sales of $550m from FY 2014-2016 were adjusted lowe\u2026 https:\/\/t.co\/ht3PRx2vBo","pubdate":"20200318133927","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In our Jan 2019 report, we estimated that $MDXG's sales would stabilize around $270m and then grow again as it exited its state of turmoil","pubdate":"20200318133928","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Our prediction proved prescient \u2013 As disclosed on pg 70 of $MDXG's Super 10K, the Co expects FY 19 rev to be 25%-28\u2026 https:\/\/t.co\/PArN8QCKbB","pubdate":"20200318133928","NumFavorite":2,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We believe $MDXG shares are currently trading at a deep discount to FV. Assuming the same multiple as competitor Os\u2026 https:\/\/t.co\/wUuAhoKUtU","pubdate":"20200318133928","NumFavorite":3,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We also believe that there is considerable option value in $MDXG's attractive pipeline of late-stage clinical trial\u2026 https:\/\/t.co\/wVNVZhDThs","pubdate":"20200318133929","NumFavorite":2,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"With the restatement completed, $MDXG's period of turmoil is largely behind it, and it can now completely focus on\u2026 https:\/\/t.co\/MSb4VHr0ix","pubdate":"20200318133929","NumFavorite":5,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"DOJ settlement another positive development for @MiMedx as it puts the VA investigation behind it. Further  clears\u2026 https:\/\/t.co\/GMZPo2LJX9","pubdate":"20200406163610","NumFavorite":10,"NumShare":5,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":".@WSJ: Some \"fear Wall Street\u2019s current earnings estimates don\u2019t fully reflect the extent of the expected damage\" f\u2026 https:\/\/t.co\/fzWYBDNyM8","pubdate":"20200414190514","NumFavorite":6,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We\u2019re short restaurant equipment supplier &amp; rollup Middleby Corp $MIDD. Wall St\u2019s V-shaped recovery narrative doesn\u2026 https:\/\/t.co\/JKe8tCRMzY","pubdate":"20200415135854","NumFavorite":37,"NumShare":10,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Middleby $MIDD is a debt-fueled roll-up that used acquisition accounting and progressively larger and lower quality\u2026 https:\/\/t.co\/AB6TIbFMLe","pubdate":"20200415144507","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Revenue from recent acquisitions deteriorated AFTER they were acquired by $MIDD.  Raises a giant red flag that\u2026 https:\/\/t.co\/aTVNanhB92","pubdate":"20200415152913","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Demand for $MIDD\u2019s equipment enters a vicious downward spiral as purchases disappear &amp; used equipment floods the ma\u2026 https:\/\/t.co\/6DX5UkZ2lC","pubdate":"20200415163437","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Channel checks reveal commercial foodservice equipment purchases are down as much as 85% and some distributors are\u2026 https:\/\/t.co\/G0GfaUJkiy","pubdate":"20200415171633","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"As demand disappears and leverage hovers near all-time highs, $MIDD's debt-fueled roll-up strategy is set to implod\u2026 https:\/\/t.co\/DJmdXaQL2Q","pubdate":"20200415180208","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Despite unprecedented hurdles, sellside expects V shaped recovery &amp; record profit\/margins in FY21.  CFS margins dec\u2026 https:\/\/t.co\/NIIn6ojX6W","pubdate":"20200415190138","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Street is way too optimistic about V shaped recovery for $MIDD \u2013 restaurant sector was decimated in recent retail s\u2026 https:\/\/t.co\/ARq7nBERyM","pubdate":"20200416145220","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Even if economic recovery is a V, it\u2019s doubtful restaurants will fully participate &amp; even if they do, $MIDD won\u2019t p\u2026 https:\/\/t.co\/7BurYjvRyU","pubdate":"20200416152825","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Remember, $MIDD customers were already slowing capex and pushing out projects BEFORE COVID-19 and several large fra\u2026 https:\/\/t.co\/RpTD38SmTK","pubdate":"20200416160210","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Large foodservice equipment distributors told us equipment purchases were down as much as 85% with no recovery in s\u2026 https:\/\/t.co\/kk5a2Gdat4","pubdate":"20200416163125","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Distributors also said they were trying to put inventory back to suppliers and reducing future purchases in prepara\u2026 https:\/\/t.co\/MxvLWyZWrJ","pubdate":"20200416170042","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Looking forward to joining @OJRenick on the @TDANetwork today to talk $MIDD and other things we're looking at. Tune\u2026 https:\/\/t.co\/j0f3lyhfHN","pubdate":"20200416175916","NumFavorite":6,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"This is exactly what we wrote in our report on @Middleby\n$MIDD https:\/\/t.co\/qGzARXCll6","pubdate":"20200424130923","NumFavorite":4,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Bad news for $MIDD.  Pizza Hut and KFC operator $YUMC expects an \u201cextended\u201d recovery period in China, an ominous si\u2026 https:\/\/t.co\/EKB0NguXsN","pubdate":"20200430154050","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Even though quarantine measures have been lifted, $YUMC says customers are still avoiding going out. https:\/\/t.co\/bgyfQTi2l4","pubdate":"20200430194358","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"McDonald's $MCD doesn\u2019t see a V-shaped recovery in China either. Recall, $MCD is also one of $MIDD\u2019s largest custom\u2026 https:\/\/t.co\/FHHXhB8b3z","pubdate":"20200501145319","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Commentary from $MCD echoes that of $YUMC that customers have not reverted back to pre-shutdown routines. $MIDD https:\/\/t.co\/az4xUva2VG","pubdate":"20200501155644","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"McDonald\u2019s $MCD also cut FY 20 capex by almost half. $MIDD https:\/\/t.co\/ZdocRDjJFT","pubdate":"20200501172731","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Bond King @TruthGundlach the data you've heard about is published by the Fed.  We've been following it on a weekly\u2026 https:\/\/t.co\/GluOiyBzEJ","pubdate":"20200502002857","NumFavorite":9,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Middleby $MIDD peers $WBT and $ITW reported Q1 revs down 12% and 7%, respectively.  Street has $MIDD Q1 revs down o\u2026 https:\/\/t.co\/H583SVDpxk","pubdate":"20200505183119","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Welbilt $WBT also said the hot-side was down even more than the cold-side (i.e. refrigeration).  Recall, $MIDD is h\u2026 https:\/\/t.co\/IXyRM3rBVd","pubdate":"20200505184141","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In addition, $WBT acknowledged that used equipment could negatively impact demand for new equipment for a period of\u2026 https:\/\/t.co\/oWHnH3g9ra","pubdate":"20200505185253","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Middleby\u2019s $MIDD Q1 headline #\u2019s may appear alright, but it\u2019s ugly under the hood. Organic Commercial Foodservice r\u2026 https:\/\/t.co\/8SXxqVLhmv","pubdate":"20200507180129","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"April order rates in China are still down 25%, not a reassuring sign for a quick recovery in the US. https:\/\/t.co\/fJFXswa0de","pubdate":"20200507182205","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Inventory &amp; DSIs spiked to record highs. $MIDD was already carrying bloated inventory before the crisis, now it\u2019s e\u2026 https:\/\/t.co\/lhS3Yv19vQ","pubdate":"20200507183927","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Customers appear to be slowing payments too.  DSOs also spiked to record highs. $MIDD https:\/\/t.co\/fFLgVAd4va","pubdate":"20200507190000","NumFavorite":0,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Divergent views: $WBT warned used equipment could negatively impact demand. $MIDD said the opposite, that it won\u2019t\u2026 https:\/\/t.co\/iT5ekk6AvO","pubdate":"20200507191943","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"In the recently released 10Q, $MIDD's pro forma revenue decline accelerated to over 7%.  The rapid deterioration im\u2026 https:\/\/t.co\/Pd3Quu3zgx","pubdate":"20200511170957","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$ORGO, a $MDXG competitor in the allograft space, provided an encouraging update regarding the current status of an\u2026 https:\/\/t.co\/7doJ5SWNV6","pubdate":"20200515130654","NumFavorite":9,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$ORGO said that ~80% of wound care centers were now open (up from ~70% in April) and that more than 50% of wound ca\u2026 https:\/\/t.co\/ebEv1JaoYi","pubdate":"20200515130654","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$ORGO reported that its advanced wound care sales had recently stabilized &amp; begun to inflect upwards due to the reo\u2026 https:\/\/t.co\/CRk0AtTDTj","pubdate":"20200515130654","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Overall, these positive developments strongly support our view that the impact of COVID-19 on $MDXG will ultimately\u2026 https:\/\/t.co\/h8YabBGUAI","pubdate":"20200515130655","NumFavorite":6,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$ORGO also stated that, because a large portion of allograft treatments are non-elective, the delaying of treatment\u2026 https:\/\/t.co\/HlapJx9FIU","pubdate":"20200515130655","NumFavorite":3,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Dire news for $MIDD. @OpenTable says 1 in 4 restaurants won't re-open. The recovery will be long and drawn out, not\u2026 https:\/\/t.co\/ltVE5KWegk","pubdate":"20200515133159","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"As $MDLA shares rebound off the lows, insiders continue to dump shares. Yet another late Friday night filing reveal\u2026 https:\/\/t.co\/q98OXRDnWM","pubdate":"20200526140901","NumFavorite":1,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Despite rebounding to pre-crisis levels, Q120 results show $MDLA continues to mask deteriorating org. growth with M\u2026 https:\/\/t.co\/MUZ7pfE1mv","pubdate":"20200603131646","NumFavorite":1,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Since May 2019, $MDLA has done ~$170M of M&amp;A.  We estimate FY 21 alone will include over $20M of inorganic revenue\u2026 https:\/\/t.co\/MSAeA1FFt0","pubdate":"20200603132418","NumFavorite":5,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We are short Enphase Energy Inc. (@enphase). Our extensive research reveals smoking gun evidence of massive fraud b\u2026 https:\/\/t.co\/R1kwDsgeqJ","pubdate":"20200617133005","NumFavorite":318,"NumShare":50,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"According to former employees, $ENPH offshored key finance &amp; accounting functions to India in late 2018, and is usi\u2026 https:\/\/t.co\/eYsJSfvkl8","pubdate":"20200617133814","NumFavorite":13,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Based on our research, we also believe that most, if not all, of the enormous 2,080 Bps expansion in $ENPH's gross\u2026 https:\/\/t.co\/Wp5tWYcU5x","pubdate":"20200617135933","NumFavorite":10,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"The claim by former employees that @Enphase is using its offshore team to help cook its books is supported by the s\u2026 https:\/\/t.co\/YNQtNE5T1F","pubdate":"20200617141134","NumFavorite":9,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Several $ENPH have questionable backgrounds, among them is CFO Eric Branderiz who previously was CAO of $TSLAQ, a c\u2026 https:\/\/t.co\/pgS9tRfvTT","pubdate":"20200617141558","NumFavorite":12,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@Enphase Almost all of the former $ENPH employees who spoke with our private investigators either claimed or believ\u2026 https:\/\/t.co\/GYBOUngHKc","pubdate":"20200617144000","NumFavorite":3,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@Enphase Based on their frantic &amp; massive share sales from June 1st to June 15th, it appears $ENPH execs &amp; board me\u2026 https:\/\/t.co\/CB1jdK4IMP","pubdate":"20200617145500","NumFavorite":2,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@Enphase We believe $ENPH's previous largest shareholder, Isidoro Quiroga, also learned of our private investigatio\u2026 https:\/\/t.co\/a7TzD02kdR","pubdate":"20200617151500","NumFavorite":4,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"@Enphase $ENPH has stacked its executive teams in both the US and India with numerous loyal, former colleagues from\u2026 https:\/\/t.co\/sXYQQuLjwV","pubdate":"20200617152700","NumFavorite":6,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"According to former employees, Ahmad Chatila, the disgraced former SunEdison CEO, is working behind-the-scenes for\u2026 https:\/\/t.co\/mje7mlHrA0","pubdate":"20200617161125","NumFavorite":2,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"According to former employees, a significant portion of $ENPH's astronomical growth over the past two years is attr\u2026 https:\/\/t.co\/07LpcxALEh","pubdate":"20200617162753","NumFavorite":4,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"According to an employee of a distributor in India, his\/her company severed its ties with $ENPH based on its belief\u2026 https:\/\/t.co\/3xrMyABwXs","pubdate":"20200617163420","NumFavorite":4,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Wood Mackenzie data shows that $ENPH's market share declined by 518 Bps from 25.4% in FY\u201917 to 20.3% in FY\u201919, whic\u2026 https:\/\/t.co\/bKFUOpRknm","pubdate":"20200617165103","NumFavorite":10,"NumShare":0,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Large distributors of $ENPH products in the US, accounting for ~69.5% of the distributor market, reported growth in\u2026 https:\/\/t.co\/Pg06rKY9OF","pubdate":"20200617180425","NumFavorite":5,"NumShare":3,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"The nearly impossible reduction in $ENPH's unit costs from Q3\u201918 to Q3\u201919 of 23.6%, or 37.6% on a tariff-adj. basis\u2026 https:\/\/t.co\/TARNx7C4JX","pubdate":"20200617183146","NumFavorite":6,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"$ENPH https:\/\/t.co\/gDXGkx8GLL","pubdate":"20200617184128","NumFavorite":9,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Still no response from $ENPH management addressing the overwhelming evidence presented in our report.  Very telling.","pubdate":"20200618172504","NumFavorite":16,"NumShare":9,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"This morning $ENPH sellside analysts tried to defend the Company and failed miserably in their analyses. We plan on\u2026 https:\/\/t.co\/Ky5yZSiVoz","pubdate":"20200618193345","NumFavorite":11,"NumShare":2,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Also encouraging is $MDXG's positive clinical trial updates. Specifically, prelim results of its knee OA &amp; plantar\u2026 https:\/\/t.co\/i93ubrn7JN","pubdate":"20200707130435","NumFavorite":12,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Particularly encouraging is the positive trend in $MDXG's rev. Excl a $30m accounting benefit, FY19 rev was $270m -\u2026 https:\/\/t.co\/cmGwJn8B96","pubdate":"20200707130435","NumFavorite":9,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Today is a great day for @MiMedx &amp; its shareholders \u2013 After more than a yr of effort, $MDXG has filed its FY19 10K\u2026 https:\/\/t.co\/Y6KmfPACqx","pubdate":"20200707130435","NumFavorite":16,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"The future is bright for $MDXG. With its fin reporting issues fully behind it, we expect its shares will be reliste\u2026 https:\/\/t.co\/8z2qdkP3Q0","pubdate":"20200707130435","NumFavorite":14,"NumShare":2,"CrawlerDate":"20200720"}]